Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 9780193, 5 pages
http://dx.doi.org/10.1155/2016/9780193
Research Article

A Case-Control Study on the Oxidative Balance of 50% Autologous Serum Eye Drops

1Faculty of Medicine, Universidade Federal de São Paulo, 04023-062 São Paulo, SP, Brazil
2Hospital de Clínicas de Porto Alegre, 90035-903 Porto Alegre, RS, Brazil
3Faculty of Medicine, Universidade Federal do Rio Grande do Sul, 90035-190 Porto Alegre, RS, Brazil
4Laboratory of Cardiovascular Physiology, Universidade Federal do Rio Grande do Sul, 90035-190 Porto Alegre, RS, Brazil
5Department of Ophthalmology, Universidade Federal de São Paulo, 04023-062 São Paulo, SP, Brazil

Received 3 June 2016; Accepted 21 July 2016

Academic Editor: Alessandra Ricelli

Copyright © 2016 Patrícia Ioschpe Gus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. Pan, A. Angelina, A. Zambrano et al., “Autologous serum eye drops for dry eye,” The Cochrane Database of Systematic Reviews, vol. 8, Article ID CD009327, 2013. View at Google Scholar · View at Scopus
  2. M. Dogru and K. Tsubota, “Pharmacotherapy of dry eye,” Expert Opinion on Pharmacotherapy, vol. 12, no. 3, pp. 325–334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. G. G. Quinto, M. Campos, and A. Behrens, “Autologous serum for ocular surface diseases,” Arquivos Brasileiros de Oftalmologia, vol. 71, no. 6, pp. 47–54, 2009. View at Google Scholar · View at Scopus
  4. K. Tsubota, E. Goto, S. Shimmura, and J. Shimazaki, “Treatment of persistent corneal epithelial defect by autologous serum application,” Ophthalmology, vol. 106, no. 10, pp. 1984–1989, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. B. A. Noble, R. S. K. Loh, S. MacLennan et al., “Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease,” British Journal of Ophthalmology, vol. 88, no. 5, pp. 647–652, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Geerling, S. MacLennan, and D. Hartwig, “Autologous serum eye drops for ocular surface disorders,” British Journal of Ophthalmology, vol. 88, no. 11, pp. 1467–1474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Matsumoto, M. Dogru, E. Goto et al., “Autologous serum application in the treatment of neurotrophic keratopathy,” Ophthalmology, vol. 111, no. 6, pp. 1115–1120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Tsubota, E. Goto, H. Fujita et al., “Treatment of dry eye by autologous serum application in Sjogren's syndrome,” British Journal of Ophthalmology, vol. 83, no. 4, pp. 390–395, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Tananuvat, M. Daniell, L. J. Sullivan et al., “Controlled study of the use of autologous serum in dry eye patients,” Cornea, vol. 20, no. 8, pp. 802–806, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. T. H. Wakamatsu, M. Dogru, Y. Matsumoto et al., “Evaluation of lipid oxidative stress status in Sjögren syndrome patients,” Investigative Ophthalmology and Visual Science, vol. 54, no. 1, pp. 201–210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Ioschpe Gus, A. Belló-Klein, S. Llesuy, G. Goulart Quinto, G. Herrmann Matos, and S. J. Bechara, “Potencial antioxidativo da lágrima de adultos jovens,” Arquivos Brasileiros de Oftalmologia, vol. 69, no. 4, pp. 565–570, 2006. View at Publisher · View at Google Scholar
  12. M. Nita and A. Grzybowski, “The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3164734, 23 pages, 2016. View at Publisher · View at Google Scholar
  13. K. Tsubota, M. Kawashima, T. Inaba et al., “The antiaging approach for the treatment of dry eye,” Cornea, vol. 31, supplement 1, pp. S3–S8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Rieger, M. Klieber, W. Schimetta et al., “The effect of iodide iontophoresis on the antioxidative capacity of the tear fluid,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 11, pp. 1639–1646, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Nakamura, M. Shibuya, H. Nakashima et al., “Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye,” Investigative Ophthalmology and Visual Science, vol. 48, no. 4, pp. 1552–1558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Uchino, T. Kawakita, T. Ishii, N. Ishii, and K. Tsubota, “A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland,” Cornea, vol. 31, supplement 1, pp. S63–S67, 2012. View at Publisher · View at Google Scholar
  17. J. Horwath-Winter, O. Schmut, E.-M. Haller-Schober, A. Gruber, and G. Rieger, “Iodide iontophoresis as a treatment for dry eye syndrome,” British Journal of Ophthalmology, vol. 89, no. 1, pp. 40–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Kojima, T. H. Wakamatsu, M. Dogru et al., “Age-related dysfunction of the lacrimal gland and oxidative stress: evidence from the Cu,Zn-superoxide dismutase-1 (Sod1) knockout mice,” The American Journal of Pathology, vol. 180, no. 5, pp. 1879–1896, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Buddi, B. Lin, S. R. Atilano, N. C. Zorapapel, M. C. Kenney, and D. J. Brown, “Evidence of oxidative stress in human corneal diseases,” Journal of Histochemistry and Cytochemistry, vol. 50, no. 3, pp. 341–351, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Arnal, C. Peris-Martínez, J. L. Menezo, S. Johnsen-Soriano, and F. J. Romero, “Oxidative stress in keratoconus?” Investigative Ophthalmology and Visual Science, vol. 52, no. 12, pp. 8592–8597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Deng, X. Hua, J. Li et al., “Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells,” PLoS ONE, vol. 10, no. 5, article e0126561, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. H. H. H. W. Schmidt, R. Stocker, C. Vollbracht et al., “Antioxidants in translational medicine,” Antioxidants and Redox Signaling, vol. 23, no. 14, pp. 1130–1143, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Kojima, R. Ishida, M. Dogru et al., “The effect of autologous serum eyedrops in the treatment of severe dry eye disease: A Prospective Randomized Case-control Study,” American Journal of Ophthalmology, vol. 139, no. 2, pp. 242–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Hussain, R. M. Shtein, A. Sugar et al., “Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease,” Cornea, vol. 33, no. 12, pp. 1245–1251, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. B. H. Jeng and W. J. Dupps Jr., “Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects,” Cornea, vol. 28, no. 10, pp. 1104–1108, 2009. View at Publisher · View at Google Scholar · View at Scopus